https://www.selleckchem.com/pr....oducts/telacebec-q20
24 vs 7.17, p = 0.01), lower PaO (47 vs 145, p 0.01), and a lower PaCO (55 vs 73, p = 0.01). Among patients with a positive AT using PaCO threshold alone, the frequency of patients with post-AT pH 7.30 was 95% (83/87). Implementing a BD criteria requiring both arterial pH and PaCO thresholds reduced the total number of positive ATs; these inconclusive cases would have required longer duration of AT to reach both targets, repeated ATs, or ancillary studies to confirm BD. The impact of this on the overall number BD declar
Like
Comment
Share
